Probiotics for Constipation in Parkinson Disease A Randomized Placebo-Controlled Study

被引:136
|
作者
Tan, Ai Huey [1 ,2 ,3 ]
Lim, Shen-Yang [1 ,2 ,3 ]
Chong, Kah Kian [1 ,2 ,3 ]
Manap, Mohammad Addin Azhan A. [1 ,2 ,3 ]
Hor, Jia Wei [1 ,2 ,3 ]
Lim, Jia Lun [1 ,2 ,3 ]
Low, Soon Chai [1 ,2 ,3 ]
Chong, Chun Wie [4 ]
Mahadeva, Sanjiv [5 ]
Lang, Anthony E. [6 ,7 ]
机构
[1] Univ Malaya, Fac Med, Div Neurol, Kuala Lumpur, Malaysia
[2] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia
[3] Univ Malaya, Fac Med, Mah Pooi Soo & Tan Chin Nam Ctr Parkinsons & Rela, Kuala Lumpur, Malaysia
[4] Monash Univ Malaysia, Sch Pharm, Subang Jaya, Selangor, Malaysia
[5] Univ Malaya, Fac Med, Dept Med, Div Gastroenterol, Kuala Lumpur, Malaysia
[6] Toronto Western Hosp, Safra Program Parkinsons Dis, Toronto, ON, Canada
[7] Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Clin, Toronto, ON, Canada
关键词
CONTROLLED-TRIAL; SYMPTOMS; INFLAMMATION; ENTEROCOCCUS; MICROBIOME; PREBIOTICS; LEVODOPA; MARKERS; SAFETY;
D O I
10.1212/WNL.0000000000010998
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To determine whether probiotics are effective for constipation, a common and often difficultto-treat problem, in Parkinson disease (PD). Methods In this double-blind, randomized, placebo-controlled, single-center trial, 280 patients with PD were screened, and 72 eligible patients were block-randomized (1:1) to receive either multistrain probiotics capsules (n = 34) or identical-appearing placebo (n = 38), for 4 weeks. The primary endpoint was the change in the average number of spontaneous bowel movements (SBM) per week during the last 2 weeks of intervention compared with the 2-week preintervention phase, recorded by daily stool diary. Secondary outcome measures included changes in stool consistency, constipation severity score, and quality of life related to constipation. Satisfaction with intervention received was assessed. Change in levels of fecal calprotectin, a marker of intestinal inflammation, was an exploratory outcome. Results SBM increased by 1.0 +/- 1.2 per week after treatment with probiotics and decreased by 0.3 +/- 1.0 per week in the placebo group (mean difference 1.3, 95% confidence interval 0.8-1.8, p < 0.001). Significant improvements were also seen for secondary outcomes after correction for multiple comparisons, including stool consistency (p = 0.009) and quality of life related to constipation (p = 0.001). In the treatment group, 65.6% reported satisfaction with the intervention vs only 21.6% in the placebo group (p < 0.001). One patient (2.9%) in the treatment group withdrew due to a nonserious adverse event. Fecal calprotectin did not change significantly during the study. Conclusions Multistrain probiotics treatment was effective for constipation in PD. Further studies are needed to investigate the long-term efficacy and safety of probiotics in PD, as well as their mechanisms of action. Classification of Evidence This study provides Class I evidence that, for people with PD, multistrain probiotics significantly increased the average number of SBM per week.
引用
收藏
页码:E772 / E782
页数:11
相关论文
共 50 条
  • [1] A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson's disease
    Chong, K. K.
    Lim, S. Y.
    Manap, M. A. A. A.
    Lim, J. L.
    Low, S. C.
    Mahadeva, S. K.
    Tan, A. H.
    MOVEMENT DISORDERS, 2018, 33 : S194 - S194
  • [2] Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study
    Zangaglia, Roberta
    Martignoni, Emilia
    Glorioso, Margaret
    Ossola, Maria
    Riboldazzi, Giulio
    Calandrella, Daniela
    Brunetti, Gabriele
    Pacchetti, Claudio
    MOVEMENT DISORDERS, 2007, 22 (09) : 1239 - 1244
  • [3] Effects of probiotics on clinical symptoms in Parkinson's disease: a pilot, randomized, placebo-controlled study
    Magistrelli, L.
    Contaldi, E.
    Leo, F.
    Amoruso, A.
    Pane, M.
    Mogna, L.
    Cantello, R.
    Comi, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 309 - 309
  • [4] The effect of probiotics on functional constipation in adults Double-blind, randomized, placebo-controlled study
    Rosa Mitelmao, Fabiana Cristina
    Bergamaschi, Cristiane de Cassia
    Gerenutti, Marli
    Hachel, Karin
    Silva, Marcus Tolentino
    Balcao, Victor M.
    Duarte Carvalho Vila, Marta Maria
    MEDICINE, 2021, 100 (10) : E24938
  • [5] Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease
    Ondo, W. G.
    Kenney, C.
    Sullivan, K.
    Davidson, A.
    Hunter, C.
    Jahan, I.
    McCombs, A.
    Miller, A.
    Zesiewicz, T. A.
    NEUROLOGY, 2012, 78 (21) : 1650 - 1654
  • [6] Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study
    Jin Young Yoon
    Jae Myung Cha
    Ju Kyoung Oh
    Pei Lei Tan
    Sae Hun Kim
    Min Seob Kwak
    Jung Won Jeon
    Hyun Phil Shin
    Digestive Diseases and Sciences, 2018, 63 : 2754 - 2764
  • [7] Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study
    Yoon, Jin Young
    Cha, Jae Myung
    Oh, Ju Kyoung
    Tan, Pei Lei
    Kim, Sae Hun
    Kwak, Min Seob
    Jeon, Jung Won
    Shin, Hyun Phil
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (10) : 2754 - 2764
  • [8] Role of zonisamide in advanced Parkinson's disease: a randomized placebo-controlled study
    Essam, Mohamed
    Hamid, Eman
    Abushady, Eman
    El-Balkimy, Mahmoud
    Antonini, Angelo
    Shalash, Ali
    NEUROLOGICAL SCIENCES, 2024, 45 (04) : 1725 - 1734
  • [9] Role of zonisamide in advanced Parkinson’s disease: a randomized placebo-controlled study
    Mohamed Essam
    Eman Hamid
    Eman Abushady
    Mahmoud El-Balkimy
    Angelo Antonini
    Ali Shalash
    Neurological Sciences, 2024, 45 : 1725 - 1734
  • [10] Zonisamide in Advanced Parkinson's Disease: A Randomized Placebo-controlled Study in Egyptian Population
    Salim, M.
    Shalash, S.
    MOVEMENT DISORDERS, 2023, 38 : S47 - S48